Lam Research (NASDAQ:LRCX – Free Report) had its target price upped by Morgan Stanley from $331.00 to $404.00 in a research note published on Monday morning, Marketbeat reports. The brokerage currently has an overweight rating on the semiconductor company’s stock.
Several other brokerages also recently weighed in on LRCX. Mizuho set a $380.00 price target on Lam Research and gave the stock an “outperform” rating in a report on Wednesday, May 27th. Barclays reiterated an “overweight” rating and set a $335.00 target price (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. Citigroup reaffirmed a “buy” rating and issued a $450.00 price target (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Rothschild & Co Redburn raised their target price on shares of Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Finally, UBS Group reiterated a “buy” rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Twenty-eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $347.75.
Read Our Latest Stock Analysis on Lam Research
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to analysts’ expectations of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. Lam Research’s quarterly revenue was up 23.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, research analysts anticipate that Lam Research will post 5.68 earnings per share for the current year.
Lam Research Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.3%. The ex-dividend date is Wednesday, June 17th. Lam Research’s dividend payout ratio is presently 19.62%.
Insider Buying and Selling
In other news, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of the firm’s stock in a transaction on Monday, April 27th. The stock was sold at an average price of $258.66, for a total value of $1,554,546.60. Following the sale, the insider directly owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. This trade represents a 10.15% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 86,339 shares of company stock worth $27,680,267. Insiders own 0.31% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of the stock. Norges Bank purchased a new stake in shares of Lam Research in the 4th quarter valued at approximately $3,645,427,000. Price T Rowe Associates Inc. MD grew its stake in shares of Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after buying an additional 10,666,540 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in Lam Research by 781.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock worth $1,518,542,000 after purchasing an additional 10,053,978 shares during the period. Franklin Resources Inc. increased its stake in Lam Research by 57.0% during the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after buying an additional 3,671,073 shares during the period. Finally, Corient Private Wealth LLC lifted its holdings in Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock worth $890,040,000 after buying an additional 3,649,553 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Morgan Stanley raised its price target on Lam Research to $404 from $331 and kept an overweight rating, implying meaningful upside from current levels. Morgan Stanley raises price target on Lam Research
- Positive Sentiment: Susquehanna boosted its target to $475 from $385 and maintained a positive stance after channel checks pointed to improving expectations for semiconductor equipment demand. Susquehanna Lifts PT on Lam Research
- Positive Sentiment: Cantor Fitzgerald lifted its price target to $500 from $425 and said AI infrastructure buildout continues to support the investment case for Lam Research. Lam Research one of the best stocks on the rise
- Positive Sentiment: Goldman Sachs also raised price targets across semiconductor equipment names, helping fuel a broader rally in Lam Research and peers this morning. Chip stocks driving today’s rally
- Neutral Sentiment: Investors are waiting for Lam Research’s upcoming earnings report, with analysts expecting double-digit bottom-line growth and watching guidance closely for confirmation of AI-related demand trends. What you need to know ahead of Lam Research’s earnings release
- Negative Sentiment: Some investors remain cautious, with one fund calling Lam Research overvalued and another report highlighting concerns that AI demand could be normalizing after a strong run. Lam Research stock falls as AI demand fears clash with guidance
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
